IP Library Granted Patent US 9,186,382
Granted Patent B2
US 9,186,382 · App. 13/691,508 · Granted Nov 17, 2015

Placental tissue grafts produced by chemical dehydration/freeze-drying and methods for making and using the same

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,186,382
App. No.
13/691,508
Granted
Nov 17, 2015
Kind
B2
Abstract

Described herein are placental tissue grafts produced by chemical dehydration followed by freeze-drying the placental tissue to produce the tissue graft. The tissue grafts retain their biological properties preferably at the same level as the placental tissues before they are processed. The placental tissue grafts have numerous medical applications. Methods for making the tissue graft compositions are also described herein.

Claims (13)

1. A method for producing a placental tissue graft comprising:

a. laminating at least two placental tissues together;

b. chemically dehydrating the placental tissues; and

c. freeze-drying the placental tissues to produce the tissue graft,

wherein the at least two placental tissues are selected from the group comprising at least two layers of chorion, at least two layers of cellularized amnion membrane, or at least one layer of chorion and at least one layer of cellularized amnion membrane.

2. The method of claim 1 , further comprising, prior to step (a), chemically decontaminating the placental tissues.

3. The method of claim 2 , wherein the placental tissues are soaked in an antibiotic solution and/or a detergent.

4. The method of claim 2 , further comprising physically cleaning the placental tissues to remove blood clots and other contaminates.

5. The method of claim 1 , wherein step (b) comprises contacting the placental tissues with a polar organic solvent for a sufficient time in order to substantially or completely remove residual water present in the placental tissues.

6. The method of claim 5 , wherein the polar organic solvent comprises an alcohol, a ketone, an ether, an aldehyde, or any combination thereof.

7. The method of claim 5 , wherein the polar organic solvent comprises DMSO, acetone, tetrahydrofuran, ethanol, isopropanol, or any combination thereof.

8. The method of claim 1 , wherein step (b) comprises soaking the placental tissues in a polar organic solvent at room temperature.

9. The method of claim 1 , wherein the placental tissues are freeze-dried at from −50° C. to −80° C.

Assignments (8)
RELEASE OF SECURITY INTEREST Recorded Feb 5, 2024
From: HAYFIN SERVICES LLP
To: MIMEDX GROUP, INC.; MIMEDX PROCESSING SERVICES, LLC
Reel/Frame 066493/0322 →
SECURITY INTEREST Recorded Jan 25, 2024
From: MIMEDX GROUP, INC.
To: CITIZENS BANK, N.A.
Reel/Frame 066371/0136 →
PATENT SECURITY AGREEMENT Recorded Jul 2, 2020
From: MIMEDX GROUP, INC.; MIMEDX PROCESSING SERVICES, LLC
To: HAYFIN SERVICES LLP, AS COLLATERAL AGENT
Reel/Frame 053121/0833 →
RELEASE OF SECURITY INTEREST Recorded Jul 2, 2020
From: BLUE TORCH FINANCE LLC, AS COLLATERAL AGENT
To: MIMEDX GROUP, INC.; MIMEDX PROCESSING SERVICES, LLC
Reel/Frame 054075/0687 →
SECURITY INTEREST Recorded Jun 11, 2019
From: MIMEDX GROUP, INC.
To: BLUE TORCH FINANCE LLC, AS COLLATERAL AGENT
Reel/Frame 049426/0863 →
TERMINATION AND RELEASE OF SECURITY INTEREST IN PATENTS Recorded Jan 24, 2019
From: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT
To: MIMEDX GROUP, INC.
Reel/Frame 048121/0835 →
NOTICE OF GRANT OF SECURITY INTEREST IN PATENTS Recorded Oct 15, 2015
From: MIMEDX GROUP, INC.
To: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 036872/0498 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 4, 2014
From: DANIEL, JOHN; SPENCER, RANDALL; RAY, STEVEN
To: MIMEDX GROUP, INC.
Reel/Frame 032140/0244 →